NEW YORK ( TheStreet) -- CHANGE IN RATINGS, EPS Acme Packet ( APKT) numbers cut at Credit Suisse. APKT estimates were reduced through 2013. Company lowered its guidance. Outperform rating and new $77 price target. Acme Packet upgraded at Wedbush to Outperform. $45 price target. Stock is attractive following the sharp selloff, given the new contract with AT&T. Apollo ( APOL) upgraded at Credit Suisse from Neutral to Outperform. $47 price target. Estimates also boosted, given better student starts and earnings prospects. Apple ( AAPL) estimates raised, target cut at ThinkEquity. Shares of AAPL now seen reaching $450. On the other hand, estimates were increased, given continued product momentum. Buy rating. Bristol-Myers ( BMY) target boosted at BofA/Merrill. Shares of BMY now seen reaching $34. Yervoy could help drive growth in the coming quarters. Neutral rating. Broadcom ( BRCM) estimates, target reduced at Morgan Stanley. Shares of BRCM now seen reaching $40. Estimates also cut, as the chip sector appears to be in a recessionary cycle. Overweight rating. Carmax ( KMX) downgraded at Credit Suisse from Outperform to Neutral. Company is facing difficult growth comparisons. CA Tech ( CA) is downgraded to hold at TheStreet Ratings. CBS ( CBS) upgraded at Citigroup from Hold to Buy. $27 price target. Asymmetric risk-reward. Citrix Systems ( CTXS) rated new Hold at Jefferies. $62 price target. Concerned that ROI on desktop virtualization makes it a more discretionary purchase. CME Group ( CME) estimates raised at BMO through 2012. Positive guidance and September monthly statistics reported at analyst day. Outperform rating. CME Group estimates raised at UBS through 2012. Analyst day highlights multiple secular growth drivers, strong positioning. Maintain $325 price target and Buy rating. Dick's Sporting Goods ( DKS) downgraded at Credit Suisse to Neutral from Outperform. Company could see growth decelerate. Dow Chemical ( DOW) estimates, target lowered at Citigroup. Shares of DOW now seen reaching $32. Estimates also lowered given some slowdown in the company's business. Buy rating. Dow Chemical target lowered at Jefferies to $26. Demand is starting to flatten. Hold rating. Global Payments ( GPN) estimates increased at Sterne Agee through 2013. Company is seeing better currency rates and buying back more stock. Buy rating and $55 price target.
Hewlett-Packard ( HPQ) estimates, target lowered at Citigroup. Shares of HPQ now seen reaching $28. Estimates also lowered on lack of near term catalysts and multiple issues facing the company. Hewlett-Packard ( HPQ) downgraded at JP Morgan from Neutral to Underweight. $20 price target. Company faces multiple growth headwinds. Home Depot ( HD) downgraded at Goldman from Buy to Neutral. Company is seeing facing cyclical tailwinds. $36 price target. Hospira ( HSP) estimates, target cut at Citigroup. Shares of HSP now seen reaching $39. Estimates also lowered to reflect SIP and Device headwinds. Maintain Hold rating. Lazard ( LAZ) estimates, target cut at JMP. Shares of LAZ now seen reaching $40. Estimates also reduced, given lower merger and asset management results. Outperform rating. LinkedIn ( LNKD) rated new Hold at Jefferies. Valuation call, based on an $81 price target. Mednax ( MD) rated new Neutral at Credit Suisse. $67 price target. Company's expansion could be hampered by macro issues. Netflix ( NFLX) rated new Neutral at Sterne Agee. Company faces several near-term growth risks. News Corp estimates raised at BMO NWSA estimates increased through 2013, BMO Capital Markets said. Aggressive share repurchases should push EPS higher. Market Perform rating. Nielsen ( NLSN) upgraded at Goldman from Neutral to Buy. $31 price target. Company should continue to deliver solid growth. PetSmart ( PETM) downgraded at Goldman from Buy to Neutral. $46 price target. Company is facing difficult margin comparisons. Polyone ( POL) downgraded at Keybanc from Buy to Hold. Company will likely see decelerating volume growth in the current economic environment. Red Hat ( RHT) estimates, target lowered at UBS. Shares of RHT now seen reaching $50. Estimates also lowered on margin pressures due to Gluster acquisition. Buy rating. Rockwood ( ROC) upgraded at JP Morgan from Neutral to Overweight. $42 price target. Stock is inexpensive, following a 45% decline. Salesforce.com ( CRM) rated new Neutral at Ticonderoga Securities. Expenses continue to grow at a rapid pace. Sprint Nextel ( S) rated new Equal-weight at Evercore Partners. $3 price target. Company remains in transition. Thermo Fisher ( TMO) rated new Outperform at Oppenheimer. $63 price target. Company has a strong base of recurring revenue and should continue to buy back stock.
Time Warner ( TWX) target, estimates cut at BMO. Shares of TWX now seen reaching $40. Estimates also lowered on lower advertising expectations U.S. Steel ( X) is downgraded to sell by TheStreet Ratings. Verizon ( VZ) rated new Equal-weight at Evercore. Valuation call, based on a $38.50 price target. Viacom ( VIA) estimates, target lowered at BMO. Shares of VIA now seen reaching $59. Estimates also lowered on lower advertising expectations at cable networks. Outperform rating. VMware ( VMW) rated new Buy at Jefferies. $100 price target. Strong strategy of dominating x86 server virtualization and launching into adjacent areas. Walt Disney ( DIS) upgraded at Citigroup from Hold to Buy. $36 price target. Attractive valuation despite below consensus EPS.